ESR1 and breast carcinoma: Importantly, somatic loss of both Brca1 and p53 resulted in the rapid and efficient formation of highly proliferative, poorly differentiated estrogen receptor-negative mammary tumors that closely mimic human BRCA-mutated breast cancers with basal-like phenotypes [64] suggesting that other genetic events contribute to tumorigenesis.